Bookmark and Share

ALENDRONIC ACID Drug Information Page

Updated 08/09/2010 12:50:37 AM

ProductSourceDateLinkData
ALENDRONIC ACIDMHRA2009-3-4ALENDRONIC ACID-MHRA-2009-3-4MHRA has issued drug updates: Methylphenidate: updated guidance on safe and effective use in ADHD Atomoxetine: risk of psychotic or manic symptoms Antipsychotics: use in elderly patients with dementia Exenatide (Byetta): risk of severe pancreatitis and renal failure Bisphosphonates: atypical stress fractures Efalizumab (Raptiva): recommendation to suspend marketing authorisation Patient-controlled analgesia extension sets: risk of inadequate pain relief Effects of MRI on implantable drug pumps Oral bowel cleansing solutions: risk of harm

Joining this website will allow you to recieve emails about any pharmaceutial you are interested in or you can search for other pharmaceuticals on this website. Joining should only take 2 minutes.